Dr Habeebullah Life Sciences Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported revenue from operations of INR 2.012 million compared to INR 1.291 million a year ago. Loss before exceptional items and tax was INR 2.607 million compared to INR 0.992 million a year ago. Loss before tax was INR 2.607 million compared to INR 0.992 million a year ago. Loss for the period was INR 2.607 million compared to INR 0.992 million a year ago. Basic and diluted loss per share was INR 0.23 compared to INR 0.09 a year ago. For the nine months, the company reported revenue from operations of INR 3.762 million compared to INR 12.383 million a year ago. Loss before exceptional items and tax was INR 6.641 million compared to INR 1.603 million a year ago. Loss before tax was INR 6.641 million compared to INR 1.603 million a year ago. Loss for the period was INR 6.641 million compared to INR 1.603 million a year ago. Basic and diluted loss per share was INR 0.60 compared to INR 0.15 a year ago.